Oncology Icons will discuss a key oncology topic selected by Targeted Oncology readers.
In July, the Targeted Oncology Icons program recognized a few community-based oncologists who all have contributed to clinical oncology research. Thus, research became the unofficial theme of the quarter.
We know that even though oncologists/hematologists working in academia play an important role in the moving new therapies forward for the treatment of cancer, oncologists in community practices also have a part to play. Specifically, real-world data (RWD) have become highly sought after information for oncologists. Regulatory bodies like the FDA also look for RWD when deciding on whether to approve a novel therapy.
As the deadline for the October Oncology Icons award approaches, the oncology community is abuzz with multiple topics that have the potential to greatly impact the future of the field.
Which topic would you like to hear and Oncology Icon discuss next?
Nominations for the Oncology Icons award program are accepted on a rolling basis throughout the year. To be eligible for the Q3 award that will be annouced in October, please submit your nomination no later than September 15, 2023. To submit, please click here.